Literature DB >> 19606167

Posterior capsulectomy using a 25-gauge microincision vitrectomy system for preventing secondary opacification after congenital cataract surgery: outcome up to 4 years.

Samin Hong1, Gong Je Seong, Sung Soo Kim.   

Abstract

OBJECTIVE: To assess long-term outcomes of posterior capsulectomy using a 25-gauge microincision vitrectomy system (25-GV) for preventing secondary visual axis opacification after congenital cataract surgery. STUDY
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Nine eyes of 5 children who underwent posterior capsulectomy carried out with the use of a 25-GV during congenital cataract surgery.
METHODS: After removal of congenital cataract with phacoemulsification and intraocular lens implantation, the posterior capsulectomy was performed using a 25-GV. Postoperative visual outcomes were analyzed.
RESULTS: The mean follow-up period was 43.11 (SD 5.53) months. Eight eyes maintained a clear visual axis, but 1 eye required Nd:YAG capsulotomy to enlarge the opening of the capsulectomy at 7 months postoperatively. Postoperative visual acuity was maintained up to 4 years without any other complications.
CONCLUSIONS: Posterior capsulectomy using a 25-GV offers an option for preventing secondary visual axis opacification after congenital cataract surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19606167     DOI: 10.3129/i09-118

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  2 in total

1.  Comparison of different surgical approaches for pediatric cataracts: complications and rates of additional surgery during long-term follow-up.

Authors:  Camila R Koch; Newton Kara-Junior; Marcony R Santhiago; Marta Morales
Journal:  Clinics (Sao Paulo)       Date:  2019-07-29       Impact factor: 2.365

2.  Comparison between Limbal and Pars Plana Approaches Using Microincision Vitrectomy for Removal of Congenital Cataracts with Primary Intraocular Lens Implantation.

Authors:  Xin Liu; Tianyu Zheng; Xingtao Zhou; Yi Lu; Peng Zhou; Fan Fan; Yi Luo
Journal:  J Ophthalmol       Date:  2016-05-30       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.